Symptoms of peripheral vascular disease (PVD) in the foot include pain, cramping, and tingling. Treatment can slow progression and includes lifestyle changes, medication, and surgery. PVD, also known ...

A small cramp in the pinky toe does not sound serious, but physicians say it may at times be indicative of more serious blood-circulation problems. If the smallest toe continues to cramp without ...

Doctors screen for peripheral arterial disease (PAD) with an ankle-brachial index (ABI) test, which measures blood pressure in the legs. Experts recommend that anyone with PAD risk factors undergo ...

Your feet might be telling you more about your heart than you realize. While seemingly unrelated, mounting evidence suggests that foot discomfort may serve as an early warning system for ...

PHOENIX — A Surprise man who nearly lost his foot to a cardiovascular condition is sounding the alarm about peripheral arterial disease. This condition occurs when plaque builds up in a person’s blood ...

Peripheral vascular disease (PVD) is a blood circulation disorder that causes some of your blood vessels to narrow, block, or spasm. Some lifestyle changes, such as exercising and quitting smoking, ...

Though many people think of injuries or accidents when they think of amputations, more than half result from complications of cardiovascular issues, leading amputations caused by the effects of ...

John Houghton receives funding from the George Davies Charitable Trust and the National Institute for Health and Care Research. He is the trainee representative for the Vascular Surgery Specialist ...

Symptoms of peripheral artery disease often include cold feet, aching or cramping in the feet during activity, and leg ulcers. While anyone can develop peripheral artery disease, the risk for the ...

The over-the-counter supplement nicotinamide riboside, a form of vitamin B3, increased the walking endurance of patients with peripheral artery disease, a chronic leg condition for which there are few ...

CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE trial, ...